In this video, Jeff Yu, MD, MS, highlighted the possible future directions of atopic dermatitis like further development of topical therapies, combination therapies and discussions of disease ...

In this video, Jeff Yu, MD, MS, highlighted research from the Revolutionizing Atopic Dermatitis, or RAD, meeting and said the disease has “leapt to the forefront” of dermatologic diseases with ...

Findings from a recent phase 3b/4 study of upadacitinib support a treat-to-target strategy for dose escalation or reduction ...

While some topical herbal therapies may provide benefit for patients with AD, systemic herbal therapies do not provide significant benefit.

Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.

Arcutis Biotherapeutics Inc. (NASDAQ:ARQT) is one of the most promising stocks according to Wall Street analysts. On June 26, ...

Organon & Co. (NYSE:OGN) stated that the recommendation highlights the cream’s status as a steroid-free and effective option for daily disease management. It does not have precautions or label ...

The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.

The trial aims to assess the safety and efficacy of tralokinumab 300mg administered biweekly as a single agent.

The antibody treatment could compete with Sanofi’s Dupixent and Eli Lilly’s Ebgylss, while offering the potential for less ...

Researchers have found in a new systematic review and meta-analysis that higher levels of environmental pollutants and ...

Treatment with dupilumab is associated with weight gain in about two thirds of adults with atopic dermatitis over 3-6 months, according to a retrospective study.